insights_auto
Kwa nini INO imeongezeka kwa 2.86%?
Fahamu zaidichevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$Â 1.44
arrow_upward
+2.86%(+0.040) Siku 1
17 Nov, 09:37:09 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya INO...
Fungua
US$Â 1.38
Juu
US$Â 1.45
Chini
US$Â 1.37
Mtaji wa soko
268.79M
Wastani wa kiasi cha mauzo
19.46M
Kiasi cha mauzo ya hisa
elfu 246.97
Juu kwa wiki 52
US$Â 2.72
Chini kwa wiki 52
US$Â 0.56
EPS
-US$Â 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Fungua
US$Â 1.38
Juu
US$Â 1.45
Chini
US$Â 1.37
Mtaji wa soko
268.79M
Wastani wa kiasi cha mauzo
19.46M
Kiasi cha mauzo ya hisa
elfu 246.97
Juu kwa wiki 52
US$Â 2.72
Chini kwa wiki 52
US$Â 0.56
EPS
-US$Â 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Business Journals
·
saa 1 iliyopita
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
MarketWatch
·
saa 16 zilizopita
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
Wasifu
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Kuhusu Inovio Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Jacqueline Shea
Wafanyakazi112
Lilianzishwa1999
Makao makuu-
SektaHealth Care
Sekta-
Tovutiinovio.com